Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vascular Surgical Procedures | 25 | 2019 | 1469 | 3.520 |
Why?
|
Lower Extremity | 15 | 2018 | 1196 | 2.940 |
Why?
|
Ischemia | 20 | 2021 | 1893 | 2.780 |
Why?
|
Peripheral Arterial Disease | 15 | 2024 | 1305 | 2.410 |
Why?
|
Thoracic Outlet Syndrome | 3 | 2021 | 97 | 1.440 |
Why?
|
Endarterectomy, Carotid | 12 | 2022 | 560 | 1.380 |
Why?
|
Economic Competition | 4 | 2016 | 218 | 1.250 |
Why?
|
Carotid Stenosis | 11 | 2022 | 872 | 1.250 |
Why?
|
Limb Salvage | 11 | 2024 | 466 | 1.220 |
Why?
|
Intermittent Claudication | 6 | 2016 | 305 | 1.150 |
Why?
|
Aortic Aneurysm, Abdominal | 9 | 2022 | 1199 | 1.150 |
Why?
|
Peripheral Vascular Diseases | 6 | 2013 | 515 | 1.110 |
Why?
|
Amputees | 2 | 2015 | 84 | 0.910 |
Why?
|
Military Medicine | 4 | 2018 | 187 | 0.880 |
Why?
|
Stents | 12 | 2022 | 3303 | 0.820 |
Why?
|
Quality Indicators, Health Care | 6 | 2019 | 1822 | 0.780 |
Why?
|
Veins | 5 | 2016 | 765 | 0.760 |
Why?
|
Surgical Procedures, Operative | 7 | 2019 | 1919 | 0.760 |
Why?
|
Chi-Square Distribution | 13 | 2017 | 3466 | 0.720 |
Why?
|
Vascular Patency | 10 | 2016 | 901 | 0.710 |
Why?
|
Commerce | 2 | 2016 | 604 | 0.700 |
Why?
|
Leg | 5 | 2013 | 1091 | 0.680 |
Why?
|
Healthcare Disparities | 6 | 2018 | 3381 | 0.670 |
Why?
|
Multivariate Analysis | 19 | 2017 | 12156 | 0.670 |
Why?
|
Angioplasty, Balloon | 5 | 2016 | 597 | 0.670 |
Why?
|
Angioplasty | 4 | 2015 | 360 | 0.670 |
Why?
|
Vascular Grafting | 3 | 2024 | 153 | 0.650 |
Why?
|
Hematoma | 4 | 2017 | 769 | 0.650 |
Why?
|
Blood Vessel Prosthesis Implantation | 8 | 2022 | 1426 | 0.640 |
Why?
|
Postoperative Complications | 17 | 2022 | 15680 | 0.610 |
Why?
|
Seroma | 1 | 2017 | 76 | 0.560 |
Why?
|
Competitive Medical Plans | 1 | 2016 | 26 | 0.540 |
Why?
|
Surgical Wound Infection | 4 | 2017 | 1529 | 0.520 |
Why?
|
Quality of Life | 9 | 2016 | 13300 | 0.510 |
Why?
|
Length of Stay | 10 | 2019 | 6472 | 0.510 |
Why?
|
Patient Discharge | 6 | 2019 | 3475 | 0.500 |
Why?
|
Health Resources | 3 | 2013 | 936 | 0.490 |
Why?
|
Salaries and Fringe Benefits | 1 | 2017 | 258 | 0.490 |
Why?
|
Silver Compounds | 1 | 2014 | 23 | 0.480 |
Why?
|
General Surgery | 5 | 2022 | 1681 | 0.480 |
Why?
|
Treatment Outcome | 47 | 2022 | 64947 | 0.480 |
Why?
|
Risk Assessment | 28 | 2022 | 24086 | 0.460 |
Why?
|
Odds Ratio | 11 | 2017 | 9712 | 0.460 |
Why?
|
Health Care Sector | 1 | 2016 | 196 | 0.460 |
Why?
|
Time Factors | 30 | 2022 | 40133 | 0.450 |
Why?
|
Graft Occlusion, Vascular | 4 | 2024 | 560 | 0.440 |
Why?
|
Phlebography | 1 | 2014 | 325 | 0.440 |
Why?
|
Specialties, Surgical | 2 | 2018 | 389 | 0.440 |
Why?
|
Patient Readmission | 8 | 2019 | 3327 | 0.430 |
Why?
|
Ribs | 1 | 2014 | 254 | 0.430 |
Why?
|
Logistic Models | 14 | 2022 | 13311 | 0.430 |
Why?
|
Alginates | 1 | 2014 | 247 | 0.430 |
Why?
|
Bandages | 1 | 2014 | 270 | 0.420 |
Why?
|
Polyesters | 1 | 2014 | 372 | 0.410 |
Why?
|
Kidney Transplantation | 4 | 2016 | 4215 | 0.410 |
Why?
|
Endovascular Procedures | 6 | 2022 | 2135 | 0.400 |
Why?
|
Decision Support Techniques | 3 | 2017 | 2002 | 0.400 |
Why?
|
Facial Transplantation | 1 | 2015 | 221 | 0.400 |
Why?
|
Health Services Needs and Demand | 2 | 2017 | 1399 | 0.400 |
Why?
|
Anti-Infective Agents, Local | 1 | 2014 | 247 | 0.400 |
Why?
|
Fee-for-Service Plans | 1 | 2017 | 705 | 0.400 |
Why?
|
Polyethylenes | 1 | 2014 | 290 | 0.400 |
Why?
|
Analgesics, Opioid | 2 | 2018 | 3762 | 0.390 |
Why?
|
United States | 39 | 2022 | 72363 | 0.390 |
Why?
|
Patient Selection | 10 | 2020 | 4276 | 0.390 |
Why?
|
Reimbursement Mechanisms | 1 | 2017 | 664 | 0.380 |
Why?
|
Aortic Rupture | 2 | 2014 | 313 | 0.380 |
Why?
|
Proportional Hazards Models | 16 | 2016 | 12532 | 0.380 |
Why?
|
Hospital Costs | 2 | 2017 | 976 | 0.370 |
Why?
|
Pain, Postoperative | 2 | 2019 | 1718 | 0.370 |
Why?
|
Aged | 53 | 2024 | 168995 | 0.370 |
Why?
|
Health Services Accessibility | 4 | 2022 | 5396 | 0.360 |
Why?
|
Physician's Role | 1 | 2017 | 920 | 0.350 |
Why?
|
Male | 72 | 2024 | 359413 | 0.350 |
Why?
|
Health Care Costs | 4 | 2017 | 3257 | 0.340 |
Why?
|
Benchmarking | 2 | 2016 | 1043 | 0.330 |
Why?
|
Databases as Topic | 2 | 2011 | 474 | 0.330 |
Why?
|
Exercise Test | 2 | 2015 | 2125 | 0.330 |
Why?
|
Female | 73 | 2024 | 391011 | 0.330 |
Why?
|
Comorbidity | 12 | 2016 | 10552 | 0.330 |
Why?
|
Specialization | 1 | 2014 | 779 | 0.330 |
Why?
|
Wound Healing | 3 | 2017 | 2786 | 0.320 |
Why?
|
Middle Aged | 51 | 2024 | 220175 | 0.320 |
Why?
|
Hospitals | 3 | 2017 | 3929 | 0.320 |
Why?
|
Social Behavior | 1 | 2015 | 1130 | 0.320 |
Why?
|
Magnetic Resonance Angiography | 2 | 2014 | 1430 | 0.320 |
Why?
|
Quality Improvement | 6 | 2019 | 3840 | 0.320 |
Why?
|
Face | 1 | 2015 | 1017 | 0.320 |
Why?
|
Humans | 102 | 2024 | 760261 | 0.310 |
Why?
|
Risk Factors | 32 | 2024 | 74269 | 0.310 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1673 | 0.310 |
Why?
|
Data Mining | 1 | 2013 | 553 | 0.310 |
Why?
|
Ultrasonography, Doppler, Duplex | 4 | 2016 | 200 | 0.310 |
Why?
|
Health Expenditures | 2 | 2017 | 2359 | 0.300 |
Why?
|
Retrospective Studies | 42 | 2024 | 80301 | 0.300 |
Why?
|
Patient-Centered Care | 2 | 2015 | 1416 | 0.300 |
Why?
|
Women | 1 | 2009 | 224 | 0.290 |
Why?
|
Quality Assurance, Health Care | 2 | 2015 | 2178 | 0.290 |
Why?
|
Kaplan-Meier Estimate | 12 | 2016 | 6545 | 0.280 |
Why?
|
Reoperation | 8 | 2019 | 4292 | 0.280 |
Why?
|
Popliteal Artery | 3 | 2016 | 312 | 0.280 |
Why?
|
Extremities | 2 | 2014 | 867 | 0.280 |
Why?
|
Aged, 80 and over | 25 | 2019 | 58947 | 0.280 |
Why?
|
Military Personnel | 5 | 2020 | 1245 | 0.280 |
Why?
|
Azygos Vein | 1 | 2006 | 19 | 0.280 |
Why?
|
Carotid Artery Diseases | 4 | 2015 | 881 | 0.280 |
Why?
|
Critical Illness | 8 | 2016 | 2709 | 0.270 |
Why?
|
Tissue and Organ Procurement | 1 | 2014 | 944 | 0.270 |
Why?
|
Disability Evaluation | 1 | 2013 | 1826 | 0.260 |
Why?
|
Linear Models | 5 | 2017 | 5876 | 0.260 |
Why?
|
Social Support | 1 | 2015 | 2145 | 0.260 |
Why?
|
Office Visits | 2 | 2022 | 597 | 0.250 |
Why?
|
Postoperative Hemorrhage | 2 | 2012 | 422 | 0.250 |
Why?
|
Iliac Vein | 1 | 2004 | 70 | 0.240 |
Why?
|
Socioeconomic Factors | 4 | 2022 | 7803 | 0.230 |
Why?
|
Graft Survival | 6 | 2016 | 3793 | 0.230 |
Why?
|
Wounds, Nonpenetrating | 2 | 2010 | 796 | 0.230 |
Why?
|
Insurance Benefits | 2 | 2016 | 191 | 0.220 |
Why?
|
Multiple Trauma | 1 | 2006 | 370 | 0.220 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 2469 | 0.220 |
Why?
|
Liver Transplantation | 1 | 2015 | 2317 | 0.220 |
Why?
|
Databases, Factual | 4 | 2019 | 8018 | 0.220 |
Why?
|
Pain | 1 | 2018 | 5066 | 0.210 |
Why?
|
Arterial Occlusive Diseases | 3 | 2019 | 752 | 0.210 |
Why?
|
Hospital Mortality | 3 | 2015 | 5420 | 0.200 |
Why?
|
Diagnostic Imaging | 2 | 2014 | 3526 | 0.200 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2017 | 10340 | 0.200 |
Why?
|
Survivors | 1 | 2013 | 2367 | 0.200 |
Why?
|
Sex Factors | 6 | 2018 | 10530 | 0.200 |
Why?
|
Emergencies | 2 | 2019 | 1217 | 0.190 |
Why?
|
Registries | 11 | 2022 | 8449 | 0.190 |
Why?
|
Vascular Diseases | 1 | 2010 | 1180 | 0.190 |
Why?
|
Macrolides | 1 | 2022 | 206 | 0.190 |
Why?
|
Health Facility Environment | 1 | 2021 | 32 | 0.190 |
Why?
|
Tissue Donors | 3 | 2016 | 2314 | 0.190 |
Why?
|
Hospital Bed Capacity | 2 | 2014 | 210 | 0.190 |
Why?
|
Residence Characteristics | 3 | 2017 | 2058 | 0.180 |
Why?
|
Aorta, Thoracic | 2 | 2006 | 1097 | 0.180 |
Why?
|
Boston | 7 | 2016 | 9282 | 0.180 |
Why?
|
Femoral Artery | 3 | 2016 | 831 | 0.180 |
Why?
|
Stroke | 7 | 2022 | 9945 | 0.180 |
Why?
|
California | 2 | 2015 | 1416 | 0.180 |
Why?
|
Subclavian Artery | 1 | 2021 | 133 | 0.180 |
Why?
|
Diffusion of Innovation | 2 | 2017 | 730 | 0.180 |
Why?
|
Insurance | 1 | 2021 | 114 | 0.180 |
Why?
|
Adult | 23 | 2022 | 219847 | 0.170 |
Why?
|
Iliac Artery | 2 | 2019 | 344 | 0.160 |
Why?
|
Insurance Carriers | 1 | 2021 | 156 | 0.160 |
Why?
|
Body Mass Index | 1 | 2017 | 12901 | 0.160 |
Why?
|
Recovery of Function | 4 | 2015 | 2982 | 0.160 |
Why?
|
After-Hours Care | 1 | 2019 | 101 | 0.160 |
Why?
|
Veterans Health | 2 | 2018 | 216 | 0.160 |
Why?
|
Imaging, Three-Dimensional | 1 | 2012 | 4044 | 0.160 |
Why?
|
Health Services Research | 3 | 2013 | 1811 | 0.160 |
Why?
|
Cohort Studies | 11 | 2018 | 41317 | 0.160 |
Why?
|
Health Benefit Plans, Employee | 2 | 2019 | 333 | 0.150 |
Why?
|
Aneurysm | 1 | 2021 | 337 | 0.150 |
Why?
|
Renal Insufficiency | 2 | 2014 | 820 | 0.150 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2019 | 389 | 0.140 |
Why?
|
Ambulatory Care | 2 | 2019 | 2783 | 0.140 |
Why?
|
Medicare | 6 | 2022 | 6771 | 0.140 |
Why?
|
Incidence | 8 | 2016 | 21378 | 0.140 |
Why?
|
Comparative Effectiveness Research | 3 | 2022 | 718 | 0.140 |
Why?
|
Analgesia, Epidural | 1 | 2019 | 330 | 0.130 |
Why?
|
Trust | 1 | 2021 | 528 | 0.130 |
Why?
|
Research Design | 5 | 2021 | 6181 | 0.130 |
Why?
|
Follow-Up Studies | 12 | 2015 | 39254 | 0.130 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2022 | 781 | 0.130 |
Why?
|
National Health Insurance, United States | 1 | 2016 | 100 | 0.130 |
Why?
|
Treatment Failure | 2 | 2015 | 2646 | 0.130 |
Why?
|
Saphenous Vein | 2 | 2012 | 538 | 0.130 |
Why?
|
Societies, Medical | 3 | 2018 | 3903 | 0.130 |
Why?
|
Waist-Hip Ratio | 1 | 2017 | 516 | 0.130 |
Why?
|
Intraoperative Care | 1 | 2019 | 768 | 0.130 |
Why?
|
Surgical Wound Dehiscence | 1 | 2017 | 217 | 0.130 |
Why?
|
Propensity Score | 4 | 2022 | 1918 | 0.130 |
Why?
|
Reproducibility of Results | 5 | 2015 | 20048 | 0.130 |
Why?
|
Subclavian Vein | 1 | 2014 | 58 | 0.120 |
Why?
|
Oligonucleotides | 2 | 2008 | 588 | 0.120 |
Why?
|
Renal Dialysis | 2 | 2019 | 1802 | 0.120 |
Why?
|
Climate Change | 1 | 2021 | 488 | 0.120 |
Why?
|
Walking | 2 | 2015 | 1190 | 0.120 |
Why?
|
Risk Adjustment | 2 | 2016 | 601 | 0.120 |
Why?
|
Operating Rooms | 1 | 2021 | 790 | 0.120 |
Why?
|
Hexuronic Acids | 1 | 2014 | 145 | 0.120 |
Why?
|
Glucuronic Acid | 1 | 2014 | 150 | 0.120 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2001 | 1484 | 0.120 |
Why?
|
Subclavian Steal Syndrome | 1 | 2014 | 20 | 0.120 |
Why?
|
Carotid Arteries | 2 | 2015 | 951 | 0.120 |
Why?
|
Obstetrics | 1 | 2021 | 668 | 0.120 |
Why?
|
Axillary Artery | 1 | 2014 | 48 | 0.110 |
Why?
|
Diabetes Mellitus | 3 | 2013 | 5884 | 0.110 |
Why?
|
Cause of Death | 1 | 2004 | 3723 | 0.110 |
Why?
|
Unnecessary Procedures | 1 | 2017 | 413 | 0.110 |
Why?
|
Texas | 1 | 2014 | 401 | 0.110 |
Why?
|
Cost of Illness | 2 | 2017 | 1940 | 0.110 |
Why?
|
Intention to Treat Analysis | 1 | 2014 | 422 | 0.110 |
Why?
|
Postoperative Period | 1 | 2018 | 1821 | 0.110 |
Why?
|
Models, Economic | 1 | 2017 | 719 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 983 | 0.110 |
Why?
|
Geographic Information Systems | 1 | 2015 | 280 | 0.110 |
Why?
|
Subcutaneous Fat | 2 | 2013 | 393 | 0.110 |
Why?
|
Hospitals, Military | 3 | 2017 | 62 | 0.100 |
Why?
|
Preoperative Period | 1 | 2015 | 555 | 0.100 |
Why?
|
Health Care Rationing | 1 | 2016 | 435 | 0.100 |
Why?
|
Angiography | 2 | 2016 | 1605 | 0.100 |
Why?
|
Administration, Topical | 1 | 2014 | 697 | 0.100 |
Why?
|
Radiography, Interventional | 1 | 2019 | 1112 | 0.100 |
Why?
|
Health Services | 1 | 2017 | 754 | 0.100 |
Why?
|
Point-of-Care Systems | 1 | 2021 | 1208 | 0.100 |
Why?
|
Insurance, Health | 2 | 2017 | 2500 | 0.100 |
Why?
|
Double-Blind Method | 3 | 2016 | 12412 | 0.100 |
Why?
|
Inflammation | 2 | 2013 | 10757 | 0.100 |
Why?
|
Data Interpretation, Statistical | 2 | 2013 | 2696 | 0.100 |
Why?
|
Anticoagulants | 1 | 2007 | 4896 | 0.100 |
Why?
|
Preoperative Care | 3 | 2020 | 2255 | 0.100 |
Why?
|
Meglumine | 1 | 2012 | 145 | 0.100 |
Why?
|
Multicenter Studies as Topic | 1 | 2017 | 1723 | 0.100 |
Why?
|
Polyethylene Terephthalates | 1 | 2012 | 115 | 0.100 |
Why?
|
Mobility Limitation | 1 | 2015 | 402 | 0.100 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2019 | 936 | 0.100 |
Why?
|
Adrenalectomy | 1 | 2013 | 348 | 0.090 |
Why?
|
Tanzania | 1 | 2015 | 1379 | 0.090 |
Why?
|
Ultrasonography, Interventional | 2 | 2010 | 1503 | 0.090 |
Why?
|
Hospitalization | 2 | 2010 | 10761 | 0.090 |
Why?
|
Prostatectomy | 2 | 2017 | 1956 | 0.090 |
Why?
|
Models, Statistical | 2 | 2015 | 5073 | 0.090 |
Why?
|
Young Adult | 9 | 2022 | 58673 | 0.090 |
Why?
|
Caloric Restriction | 1 | 2012 | 295 | 0.090 |
Why?
|
Age Factors | 6 | 2017 | 18415 | 0.090 |
Why?
|
Needs Assessment | 1 | 2016 | 1137 | 0.090 |
Why?
|
Predictive Value of Tests | 4 | 2014 | 15273 | 0.080 |
Why?
|
Monte Carlo Method | 1 | 2015 | 1256 | 0.080 |
Why?
|
Decompression, Surgical | 1 | 2014 | 604 | 0.080 |
Why?
|
Netherlands | 1 | 2014 | 2213 | 0.080 |
Why?
|
Drug Costs | 1 | 2017 | 1184 | 0.080 |
Why?
|
Database Management Systems | 1 | 2010 | 258 | 0.080 |
Why?
|
Communication | 2 | 2021 | 3846 | 0.080 |
Why?
|
Brachytherapy | 1 | 2016 | 1240 | 0.080 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1679 | 0.080 |
Why?
|
Aortography | 1 | 2010 | 419 | 0.080 |
Why?
|
Hospitals, Teaching | 1 | 2014 | 1166 | 0.080 |
Why?
|
Gadolinium DTPA | 1 | 2012 | 826 | 0.080 |
Why?
|
Patient Care Planning | 1 | 2014 | 909 | 0.080 |
Why?
|
Hospital Charges | 1 | 2010 | 359 | 0.080 |
Why?
|
Endothelium, Vascular | 1 | 2001 | 4437 | 0.080 |
Why?
|
Transplantation, Autologous | 3 | 2009 | 2120 | 0.080 |
Why?
|
Organometallic Compounds | 1 | 2012 | 659 | 0.080 |
Why?
|
Patient Care Team | 1 | 2019 | 2510 | 0.080 |
Why?
|
Morbidity | 1 | 2013 | 1765 | 0.080 |
Why?
|
Survival Analysis | 4 | 2015 | 10185 | 0.080 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2013 | 734 | 0.070 |
Why?
|
ROC Curve | 2 | 2013 | 3568 | 0.070 |
Why?
|
Nutritional Status | 1 | 2016 | 1606 | 0.070 |
Why?
|
Electronic Health Records | 2 | 2021 | 4763 | 0.070 |
Why?
|
Pericardium | 1 | 2012 | 675 | 0.070 |
Why?
|
Vascular System Injuries | 1 | 2010 | 248 | 0.070 |
Why?
|
Blood Vessels | 1 | 2013 | 1112 | 0.070 |
Why?
|
Adiposity | 1 | 2017 | 1851 | 0.070 |
Why?
|
Prospective Studies | 6 | 2016 | 54263 | 0.070 |
Why?
|
Emergency Medicine | 1 | 2016 | 1195 | 0.070 |
Why?
|
Delayed Graft Function | 1 | 2006 | 49 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2014 | 2434 | 0.070 |
Why?
|
Photoplethysmography | 1 | 2006 | 60 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2019 | 3598 | 0.070 |
Why?
|
Severity of Illness Index | 6 | 2019 | 15827 | 0.070 |
Why?
|
Social Class | 1 | 2015 | 2005 | 0.070 |
Why?
|
Pilot Projects | 2 | 2021 | 8553 | 0.070 |
Why?
|
Inguinal Canal | 1 | 2005 | 72 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2014 | 20484 | 0.060 |
Why?
|
Decision Support Systems, Clinical | 1 | 2014 | 1162 | 0.060 |
Why?
|
Regression Analysis | 1 | 2015 | 6361 | 0.060 |
Why?
|
Patient Participation | 1 | 2014 | 1437 | 0.060 |
Why?
|
Neuroblastoma | 1 | 2013 | 1252 | 0.060 |
Why?
|
Memory | 1 | 2014 | 2179 | 0.060 |
Why?
|
Anesthesiology | 1 | 2015 | 1116 | 0.060 |
Why?
|
Aortic Aneurysm | 1 | 2009 | 646 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 3005 | 0.060 |
Why?
|
Radiography | 2 | 2006 | 6965 | 0.060 |
Why?
|
Adolescent | 5 | 2022 | 87747 | 0.060 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1882 | 0.060 |
Why?
|
Activities of Daily Living | 1 | 2013 | 2414 | 0.060 |
Why?
|
North America | 1 | 2007 | 1282 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 3215 | 0.060 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 435 | 0.060 |
Why?
|
Viscera | 1 | 2004 | 138 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2015 | 14656 | 0.060 |
Why?
|
Quality of Health Care | 1 | 2019 | 4361 | 0.060 |
Why?
|
Blood Vessel Prosthesis | 2 | 2019 | 945 | 0.060 |
Why?
|
Sex Distribution | 1 | 2008 | 2295 | 0.060 |
Why?
|
Minority Groups | 1 | 2010 | 1199 | 0.050 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2006 | 294 | 0.050 |
Why?
|
Aorta | 1 | 2010 | 2042 | 0.050 |
Why?
|
Probability | 2 | 2005 | 2476 | 0.050 |
Why?
|
Retreatment | 2 | 2016 | 600 | 0.050 |
Why?
|
Resistin | 2 | 2013 | 172 | 0.050 |
Why?
|
Computer Literacy | 1 | 2022 | 44 | 0.050 |
Why?
|
Plasminogen Activator Inhibitor 1 | 2 | 2013 | 280 | 0.050 |
Why?
|
Health Status Indicators | 1 | 2007 | 968 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8621 | 0.050 |
Why?
|
Blood Transfusion | 2 | 2019 | 1328 | 0.050 |
Why?
|
Prevalence | 2 | 2010 | 15687 | 0.050 |
Why?
|
Cardiovascular Agents | 1 | 2007 | 864 | 0.050 |
Why?
|
Hand | 1 | 2006 | 903 | 0.050 |
Why?
|
Laparoscopy | 1 | 2013 | 2155 | 0.050 |
Why?
|
Heart Diseases | 1 | 2014 | 2809 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2013 | 3293 | 0.050 |
Why?
|
Constriction, Pathologic | 2 | 2016 | 1098 | 0.040 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 1521 | 0.040 |
Why?
|
Computer Simulation | 1 | 2013 | 6210 | 0.040 |
Why?
|
Administration, Oral | 1 | 2007 | 4044 | 0.040 |
Why?
|
United States Department of Defense | 1 | 2019 | 34 | 0.040 |
Why?
|
Penicillins | 1 | 2022 | 403 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2006 | 1490 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2012 | 3335 | 0.040 |
Why?
|
Clinical Competence | 1 | 2015 | 4786 | 0.040 |
Why?
|
Information Systems | 1 | 2021 | 398 | 0.040 |
Why?
|
Graft Rejection | 3 | 2012 | 4423 | 0.040 |
Why?
|
Contrast Media | 1 | 2012 | 5301 | 0.040 |
Why?
|
Disease Progression | 1 | 2016 | 13505 | 0.040 |
Why?
|
Permeability | 1 | 2001 | 719 | 0.040 |
Why?
|
Insurance Coverage | 2 | 2022 | 1939 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2018 | 6855 | 0.040 |
Why?
|
Growth Substances | 1 | 2001 | 768 | 0.040 |
Why?
|
Telephone | 1 | 2022 | 623 | 0.040 |
Why?
|
Recurrence | 4 | 2016 | 8487 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3696 | 0.040 |
Why?
|
Liver Cirrhosis | 1 | 2008 | 1925 | 0.040 |
Why?
|
Cytokines | 1 | 2013 | 7345 | 0.040 |
Why?
|
Ultrasonography, Mammary | 1 | 2020 | 247 | 0.040 |
Why?
|
Occult Blood | 1 | 2018 | 197 | 0.040 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2004 | 693 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2015 | 25928 | 0.040 |
Why?
|
Health Status Disparities | 1 | 2009 | 1819 | 0.040 |
Why?
|
Endoleak | 1 | 2018 | 105 | 0.040 |
Why?
|
Physicians | 1 | 2015 | 4590 | 0.040 |
Why?
|
Medicaid | 1 | 2010 | 2811 | 0.040 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2022 | 464 | 0.030 |
Why?
|
Smoking | 1 | 2014 | 9070 | 0.030 |
Why?
|
Health Status | 1 | 2010 | 4081 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12968 | 0.030 |
Why?
|
Government Agencies | 1 | 2017 | 161 | 0.030 |
Why?
|
Focus Groups | 1 | 2021 | 1372 | 0.030 |
Why?
|
Internship and Residency | 1 | 2015 | 5867 | 0.030 |
Why?
|
Leptin | 2 | 2013 | 1590 | 0.030 |
Why?
|
Massachusetts | 2 | 2022 | 8805 | 0.030 |
Why?
|
Outpatients | 1 | 2022 | 1606 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2007 | 5507 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2021 | 1272 | 0.030 |
Why?
|
Insurance Claim Review | 1 | 2018 | 737 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2001 | 1335 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 934 | 0.030 |
Why?
|
Erectile Dysfunction | 1 | 2017 | 452 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2022 | 22041 | 0.030 |
Why?
|
Professional Practice | 1 | 2015 | 313 | 0.030 |
Why?
|
Watchful Waiting | 1 | 2018 | 510 | 0.030 |
Why?
|
Physician Assistants | 1 | 2015 | 188 | 0.030 |
Why?
|
Cell Division | 1 | 2001 | 4462 | 0.030 |
Why?
|
Insulin Resistance | 1 | 2007 | 3960 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1675 | 0.030 |
Why?
|
Urinary Incontinence | 1 | 2017 | 496 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36247 | 0.030 |
Why?
|
Antibiotic Prophylaxis | 1 | 2018 | 642 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21065 | 0.030 |
Why?
|
Cerebral Revascularization | 1 | 2015 | 249 | 0.030 |
Why?
|
Efficiency | 1 | 2015 | 477 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1500 | 0.030 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2018 | 867 | 0.030 |
Why?
|
Coronary Artery Bypass | 2 | 2014 | 2273 | 0.020 |
Why?
|
Heart Failure | 2 | 2014 | 11835 | 0.020 |
Why?
|
Hospitals, General | 1 | 2016 | 795 | 0.020 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2015 | 385 | 0.020 |
Why?
|
Blood Pressure | 1 | 2006 | 8523 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 2958 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 2016 | 899 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2001 | 2641 | 0.020 |
Why?
|
Polypharmacy | 1 | 2013 | 307 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2013 | 607 | 0.020 |
Why?
|
Perioperative Care | 1 | 2018 | 1032 | 0.020 |
Why?
|
Prognosis | 2 | 2010 | 29636 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2013 | 698 | 0.020 |
Why?
|
Aneurysm, False | 1 | 2012 | 257 | 0.020 |
Why?
|
Mammography | 1 | 2020 | 2452 | 0.020 |
Why?
|
Public Health | 1 | 2022 | 2655 | 0.020 |
Why?
|
Survival Rate | 2 | 2014 | 12806 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2012 | 983 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2016 | 1957 | 0.020 |
Why?
|
Interleukins | 1 | 2013 | 782 | 0.020 |
Why?
|
Fees and Charges | 1 | 2008 | 191 | 0.020 |
Why?
|
Tumor Burden | 1 | 2013 | 1897 | 0.020 |
Why?
|
Appendectomy | 1 | 2010 | 431 | 0.020 |
Why?
|
Life Tables | 1 | 2007 | 365 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3451 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 6242 | 0.020 |
Why?
|
Adiponectin | 1 | 2013 | 1115 | 0.020 |
Why?
|
Cholecystectomy | 1 | 2008 | 406 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2852 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2007 | 516 | 0.020 |
Why?
|
Cattle | 1 | 2012 | 3847 | 0.020 |
Why?
|
Child, Preschool | 2 | 2022 | 42034 | 0.020 |
Why?
|
Digestive System Surgical Procedures | 1 | 2010 | 576 | 0.020 |
Why?
|
Trauma Centers | 1 | 2010 | 934 | 0.020 |
Why?
|
Attention | 1 | 2015 | 2386 | 0.020 |
Why?
|
Brachial Artery | 1 | 2006 | 368 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2007 | 466 | 0.020 |
Why?
|
Observer Variation | 1 | 2010 | 2596 | 0.010 |
Why?
|
Models, Biological | 1 | 2001 | 9468 | 0.010 |
Why?
|
Mesenteric Artery, Superior | 1 | 2004 | 95 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7400 | 0.010 |
Why?
|
Forecasting | 1 | 2013 | 2931 | 0.010 |
Why?
|
Anesthesia | 1 | 2015 | 1584 | 0.010 |
Why?
|
Equipment Design | 1 | 2012 | 3520 | 0.010 |
Why?
|
Fingers | 1 | 2006 | 505 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2477 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2001 | 11480 | 0.010 |
Why?
|
Colectomy | 1 | 2008 | 694 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2013 | 3207 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6830 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4891 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2013 | 5201 | 0.010 |
Why?
|
Mass Screening | 1 | 2018 | 5422 | 0.010 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2013 | 1367 | 0.010 |
Why?
|
Renal Artery | 1 | 2004 | 368 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 4357 | 0.010 |
Why?
|
Bariatric Surgery | 1 | 2010 | 1006 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8058 | 0.010 |
Why?
|
Animals | 3 | 2012 | 167940 | 0.010 |
Why?
|
Chronic Disease | 1 | 2013 | 9283 | 0.010 |
Why?
|
Pregnancy | 1 | 2017 | 29725 | 0.010 |
Why?
|
Phenotype | 1 | 2013 | 16543 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 9274 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2016 | 11891 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 11341 | 0.010 |
Why?
|
Child | 1 | 2022 | 79758 | 0.010 |
Why?
|
Infant | 1 | 2013 | 36030 | 0.010 |
Why?
|
Kidney | 1 | 2006 | 7072 | 0.010 |
Why?
|
Obesity | 1 | 2013 | 12915 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 15740 | 0.000 |
Why?
|